| PUBCHEM ID |
75124280
|
| UNII |
TV5NLH8NR4
|
| Preferred Term |
ROSARAMICIN BUTYRATE
|
| CAS |
55103-30-5
|
| INCHIKEY |
BXRFQJOFRKZZPI-MZWZJCGPSA-N
|
| Download |
mol2, pdbqt
|
| mol2 |
|
| Smiles |
CCCC(O[C@@H]1[C@@H](O[C@@H]([C@H](C)[C@H](CC(O[C@@H](CC)[C@H](C)[C@H]2O[C@]2(C)/C=C2)=O)O)[C@H](CC=O)C[C@H](C)C2=O)O[C@@H](C)C[C@H]1N(C)C)=O
|
| Total Surface Area |
513,66
|
| Relative PSA |
0,24619
|
| TPSA |
141,2
|
| cLogS |
-4,813
|
| MW |
651,835
|
| cLogP |
3,5973
|
| H-Acceptors |
11
|
| H-Donors |
1
|
| Ro5 violations |
2
|
| Druglikeness |
2,4173
|
| DrugScore |
0,228450403501381
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
high
|
| Blood-Brain Barrier |
BBB-
|
| Human Intestinal Absorption |
HIA+
|
| Caco-2 Permeability I |
Caco2-
|
| Caco-2 Permeability II |
0,7731
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor I |
Inhibitor
|
| P-glycoprotein Inhibitor II |
Non-inhibitor
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Subcellular localization |
Lysosome
|
| CYP450 2C9 Substrate |
Non-substrate
|
| CYP450 2D6 Substrate |
Non-substrate
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Human Ether-a-go-go-Related Gene Inhibition I |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition II |
Non-inhibitor
|
| AMES Toxicity |
Non AMES toxic
|
| Carcinogens |
Non-carcinogens
|
| Fish Toxicity I |
High FHMT
|
| Fish Toxicity II |
1,2394
|
| Tetrahymena Pyriformis Toxicity I |
High TPT
|
| Tetrahymena Pyriformis Toxicity II |
0,5743
|
| Tetrahymena Pyriformis Toxicity |
High HBT
|
| Biodegradation |
Not ready biodegradable
|
| Acute Oral Toxicity |
III
|
| Rat Acute Toxicity |
2,6223
|
| Carcinogenicity (Three-class) |
Non-required
|
